- videocam Live Webinar with Live Q&A
- calendar_month January 13, 2027 @ 1:00 PM ET/10:00 AM PT
- signal_cellular_alt Intermediate
- card_travel Health
- schedule 90 minutes
No Surprises Act Independent Dispute Resolution: Key Legal Developments; Ongoing Challenges; Stakeholder Impact
Notable Judicial Decisions; Final Rule Overhauling Process; Proposed Legislation to Impact IDR
Welcome to BARBRI, the trusted global leader in legal education. Continue to access the same expert-led Strafford CLE and CPE webinars you know and value. Plus, explore professional skills courses and more.
About the Course
Introduction
This CLE webinar will examine the latest legal developments surrounding the No Surprises Act's (NSA) Independent Dispute Resolution (IDR) process. The panel will discuss key judicial decisions that have shaped the IDR process while vacating key regulatory provisions, new regulation attempting to streamline the IDR process, and proposed legislation to overhaul and effectively eliminate IDR entirely. The panel will discuss the impact this evolving regulatory landscape has on stakeholders and offer best practices for compliance.
Description
The NSA's IDR process was supposed to encourage and streamline settlement between providers and insurers when they could not agree on a payment amount. Rather, the IDR system has become an administrative bottleneck with an overwhelming number of disputes and inconsistent eligibility screening, among other issues, and controversy continues around calculating the qualifying payment amount (QPA). Federal courts have been inundated with challenges to both awards issued in IDR and the NSA itself.
One of the most noteworthy series of cases related to the NSA is the Texas Medical Association v. U.S. Department of Health and Human Services cases (TMA I through IV). In the most recent holding in TMA III, the en banc Fifth Circuit rejected two QPA rules central to the NSA, holding that health plans may no longer include non-negotiated "ghost rates" in QPA calculations and that plans may not categorically exclude bonus, incentive, risk-sharing, and other retrospective payments from the QPA. The TMA cases demonstrate how the federal courts continue to shape the NSA through vacating key provisions of regulations and disrupting the IDR process.
In an attempt to provide some clarity and efficiency to the IDR process, the U.S. Departments of Health & Human Services, Labor, and Treasury released new IDR regulations in May 2026 that include new disclosure requirements, standardized billing communication codes, improved information sharing before and during disputes, and lower administrative fees. Questions remain as to whether the new regulations have resolved prior challenges.
Despite these regulatory attempts to improve the IDR process, legislation has been introduced to effectively eliminate IDR. The Lower Premiums, Faster Payments Act proposes a new QPA formula, prohibits judicial review for determining the QPA, and requires mandatory audits. Under the proposed legislation, open negotiation and IDR would apply only to items and services furnished prior to Jan. 1, 2028. After that date, the QPA would become the out-of-network rate.
With the controversy and activity that continues to surround the IDR process, counsel for stakeholders should understand the latest legal trends and developments and how their clients may be impacted.
Listen as our authoritative panel provides an update on the IDR process and provides best practices for guiding stakeholders through this evolving legislative, judicial, and regulatory landscape.
Presented By
Mr. Hennessy represents traditional health care providers and life sciences companies alongside the emerging generation of digital health and AI-driven companies reshaping the industry, helping clients navigate the regulatory and transactional complexities of a rapidly evolving health care landscape. He counsels companies across the full spectrum of the industry, from physician practices, hospitals, health systems, and academic medical centers to pharmacies, clinical laboratories, medical foundations, DMEPOS suppliers, independent diagnostic testing facilities (IDTFs), federally qualified health centers (FQHCs), ambulatory surgical centers (ASCs), digital health providers and companies, telehealth providers, drug and device wholesalers, and behavioral health providers. He also represents life sciences companies and health industry-focused private equity firms, with particular experience in physician practice matters across radiology, gastroenterology, pathology, and other specialties. Mr. Hennessy's practice spans regulatory counseling, transactional work, and compliance, including the negotiation and drafting of provider agreements, acquisitions and divestitures, transactional due diligence, change of ownership matters, and the identification and resolution of regulatory concerns. He advises clients on federal and state fraud and abuse laws (Stark Law and Anti-Kickback Statute), Medicare and Medicaid participation and reimbursement, state corporate practice of medicine issues, and provider licensure and enrollment. James has particular depth in Stark Law matters, developed through years of complex physician practice representation across a wide range of specialties. Mr. Hennessy is also deeply versed in the Management Services Organization (MSO) model, having structured and implemented MSO arrangements for clients across the country, and brings market-informed guidance on structures and approaches drawn from broad experience with what leading organizations are doing in practice. He also counsels health care and life sciences companies including digital health and AI companies handling sensitive health data, on privacy and security compliance under the Health Insurance Portability and Accountability Act (HIPAA), the California Consumer Privacy Act of 2018 (CCPA), and California’s Confidentiality of Medical Information Act (CMIA).
Mr. Schutzer manages and leads complex civil litigation matters, with a focus on the healthcare industry. He regularly handles disputes involving healthcare reimbursement, coverage and regulatory issues. Mr. Schutzer has a special focus on emerging federal requirements affecting payors and providers, including the federal No Surprises Act. He also has significant government investigations experience, building on his tenure at the U.S. Department of Justice. While at DOJ he worked on investigating and litigating disability rights matters in the Civil Rights Division, including leading a team to a trial court victory in a lawsuit under Title II of the Americans with Disabilities Act. At the U.S. Attorney’s Office for the Southern District of California, Mr. Schutzer focused on healthcare fraud matters under the False Claims Act. He handled matters concerning millions of dollars of potential fraud against the Medicaid, Medicare, and TRICARE systems, often working in close partnership with the Department of Health & Human Services, the Department of Defense, the FBI, and other state and federal stakeholders. He stands ready to assist clients in resolving disputes with governmental entities and private parties alike.
-
This 90-minute webinar is eligible in most states for 1.5 CLE credits.
-
Live Online
On Demand
Date + Time
- event
Wednesday, January 13, 2027
- schedule
1:00 PM ET/10:00 AM PT
I. Introduction: overview of IDR purpose and process
II. IDR challenges
III. Notable litigation impacting IDR
A. TMA III
IV. Legislation and rulemaking related to IDR
A. 2026 HHS final rule: key process changes
B. Proposed/pending legislation
V. Stakeholder impact and best practices
VI. Key takeaways
The panel will review these and other important issues:
- What have been the main problems surrounding the IDR process since the NSA's inception?
- What are noteworthy judicial decisions impacting IDR?
- How does the May 2026 final rule attempt to streamline IDR? Has it been successful?
- What key legislation has been introduced in an attempt to solve IDR challenges?
- What best practices can guide stakeholders through the evolving legal landscape surrounding IDR?
Unlimited access to premium CLE courses:
- Annual access
- Available live and on-demand
- Best for attorneys and legal professionals
Unlimited access to premium CPE courses.:
- Annual access
- Available live and on-demand
- Best for CPAs and tax professionals
Unlimited access to premium CLE, CPE, Professional Skills and Practice-Ready courses.:
- Annual access
- Available live and on-demand
- Best for legal, accounting, and tax professionals
Unlimited access to Professional Skills and Practice-Ready courses:
- Annual access
- Available on-demand
- Best for new attorneys
Related Courses
No Surprises Act Independent Dispute Resolution: Key Legal Developments; Ongoing Challenges; Stakeholder Impact
Wednesday, January 13, 2027
1:00 PM ET/10:00 AM PT
Introduction to Healthcare M&A: Regulatory and Transaction Overview, Deal Structures, Key Terms, Pitfalls to Avoid
Monday, December 14, 2026
1:00 PM ET/10:00 AM PT
Buying and Selling Physician Practices: Legal and Business Considerations, Transaction Structure, Key Provisions
Thursday, December 3, 2026
1:00 PM ET/10:00 AM PT
Ambulatory Surgery Center Acquisitions: Minimizing Compliance Risks
Available On-Demand
Recommended Resources
Navigating Modern Legal Challenges: A Comprehensive Guide
- Business & Professional Skills
- Career Advancement